News
Empowering the biopharma industry with field-leading foundation models.
Recent News
Press
|
August 21, 2023
AI drug designer Genesis Therapeutics forges $200M round with eye on clinical testing
Fierce Biotech
Press
|
August 21, 2023
Genesis Therapeutics Closes Oversubscribed $200M Series B
Business Wire
Press
|
May 6, 2022
AI 50 2022: North America's Top AI Companies Shaping The Future
Forbes
Press
|
April 30, 2021
Genesis Therapeutics Hires Will McCarthy as Chief Business Officer
Business Wire
Press
|
April 26, 2021
AI 50 2021: America's Most Promising Artificial Intelligence Companies
Forbes
Press
|
December 2, 2020
Genesis Therapeutics Secures $52M Series A, Led by Rock Springs Capital
Business Wire
Press
|
December 2, 2020
Genesis Therapeutics raises $52M A round for its AI-focused drug discovery mission
TechCrunch
Press
|
July 3, 2020
AI 50 2020: America's Most Promising Artificial Intelligence Companies
Forbes
Join Us
Opportunities in AI and Physics Research
Our molecular AI research team is pioneering new frameworks for drug discovery, at the intersection of multi-dimensional ML models and physical simulation. See opportunities in software engineering, machine learning and computation chemistry.
Software Engineering
Machine Learning
Computational Chemistry
